Erythrodermic atopic dermatitis resistant to dupilumab and baricitinib successfully treated with upadacitinib

Journal of the European Academy of Dermatology and VenereologyVolume 37, Issue 4 p. e493-e495 LETTER TO THE EDITOR Erythrodermic atopic dermatitis resistant to dupilumab and baricitinib successfully treated with upadacitinib Clara Valente, Corresponding Author Clara Valente [email protected] orcid.org/0000-0001-6910-9248 Dermatology and Venereology Department, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal Correspondence Clara Valente, Dermatology and Venereology Department, Centro Hospitalar Universitário de Lisboa Central, Alameda de Santo António dos Capuchos, Santo António, Lisboa, Portugal. Email: [email protected]Search for more papers by this authorBruno Duarte, Bruno Duarte orcid.org/0000-0003-4757-0679 Dermatology and Venereology Department, Centro Hospitalar Universitário de Lisboa Central, Lisbon, PortugalSearch for more papers by this author Clara Valente, Corresponding Author Clara Valente [email protected] orcid.org/0000-0001-6910-9248 Dermatology and Venereology Department, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal Correspondence Clara Valente, Dermatology and Venereology Department, Centro Hospitalar Universitário de Lisboa Central, Alameda de Santo António dos Capuchos, Santo António, Lisboa, Portugal. Email: [email protected]Search for more papers by this authorBruno Duarte, Bruno Duarte orcid.org/0000-0003-4757-0679 Dermatology and Venereology Department, Centro Hospitalar Universitário de Lisboa Central, Lisbon, PortugalSearch for more papers by this author First published: 28 October 2022 https://doi.org/10.1111/jdv.18714Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. Volume37, Issue4April 2023Pages e493-e495 RelatedInformation